These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22292773)

  • 1. Anticoagulant and fibrinolytic drugs - possible agents in treatment of lung cancer?
    Bobek V
    Anticancer Agents Med Chem; 2012 Jul; 12(6):580-8. PubMed ID: 22292773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic thromboembolism with Arvin, oral fibrinolytics and standard anticoagulants.
    Kounis NG; Evans WH
    Vasc Surg; 1977; 11(2):68-72. PubMed ID: 616136
    [No Abstract]   [Full Text] [Related]  

  • 3. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor and antimetastatic effect of warfarin and heparins.
    Bobek V; Kovarík J
    Biomed Pharmacother; 2004 May; 58(4):213-9. PubMed ID: 15183845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.
    Wood S
    J Med; 1974; 5(1):7-22. PubMed ID: 4134042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of venous thromboembolism].
    Rocha E; Panizo C; Lecumberri R
    Med Clin (Barc); 2000 Jul; 115(6):224-35. PubMed ID: 11002463
    [No Abstract]   [Full Text] [Related]  

  • 9. The rationale of anticoagulants in the treatment of cancer.
    Cliffton EE; Grossi CE
    J Med; 1974; 5(1):107-13. PubMed ID: 4275504
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of anticoagulant therapy in cancer].
    Sopotsinskaia EB
    Vopr Onkol; 1976; 22(8):110-5. PubMed ID: 136805
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulant and thrombolytic therapies in women.
    Schwartz JB
    J Gend Specif Med; 2002; 5(1):14-8. PubMed ID: 11859682
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
    Raskob GE
    Curr Opin Pulm Med; 1995 Jul; 1(4):291-7. PubMed ID: 9363067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
    Pelosio L; Marasco A; Puopolo G
    Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically important drug interactions with anticoagulants. An update.
    Harder S; Thürmann P
    Clin Pharmacokinet; 1996 Jun; 30(6):416-44. PubMed ID: 8792056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of venous thromboembolic disorders: new challenges and opportunities.
    Prandoni P
    Haematologica; 2003 Jun; 88(6):610-3. PubMed ID: 12801835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.